+86 16650237703
Author:Kangdi 11-08-2026
Audience: B2B sourcing managers, OTC brand owners, private label buyers, and procurement professionals deciding between heat patch and capsicum plaster positioning for thermotherapy product lines.
Reading time: 12 minutes
What you'll get: Side-by-side comparison across 6 dimensions, 5 market-segment mapping, 4 supplier qualification criteria, 5-step OEM selection framework, and 5 FAQ.
1. Side-by-Side Comparison: 6 Dimensions
Heat patches and capsicum plasters both target thermotherapy positioning but use opposite mechanisms (physical vs pharmacological heating), opposite duration (8+ hours vs 4–6 hours), and opposite market segments. Use this 6-dimension comparison to evaluate which product suits your brand positioning.
Dimension 1 — Heating mechanism
Heat patches work through physical iron-powder oxidation: iron-powder + salt + water + oxygen-permeable membrane react exothermically upon exposure to air, generating 40–65°C heat for 6–12 hours. No active pharmacological ingredient; positioning typically cosmetic or non-drug device. Capsicum plasters work through pharmacological warming: capsaicin (capsaicinoid extract) activates TRPV1 receptor, creating warming sensation 38–42°C for 4–6 hours. Drug-positioned in US OTC monograph framework.
Dimension 2 — Active ingredient
Heat patches: none pharmacological (iron-powder, salt, water, activated carbon, oxygen-permeable membrane). Some variants integrate herbal scent (lavender, eucalyptus) for aromatherapy but not pharmacological effect. Capsicum plasters: capsaicin 0.025%–0.075% concentration typically; some variants include menthol, methyl salicylate, camphor, or nonivamide.
Dimension 3 — Regulatory pathway
Heat patches: US (cosmetic per MoCRA / device per FDA 21 CFR 807 / general OTC if no claims); EU (cosmetic per Regulation 1223/2009 / medical device per MDR Class I); GCC (cosmetic notification / SFDA); NMPA (cosmetic / medical device / no registration if general warming). Capsicum plasters: US (21 CFR 348 OTC topical analgesic monograph if capsaicin at monograph concentration; otherwise cosmetic); EU (MDR Class IIa medical device); GCC (SFDA registration); NMPA (medical device / OTC).
Dimension 4 — Manufacturing complexity
Heat patches: low to medium complexity — iron-powder formulation, oxygen-permeable membrane sealing, packaging integrity testing (oxygen barrier during storage). Capsicum plasters: medium complexity — rubber-based or acrylic adhesive matrix, capsaicin extraction or synthetic capsaicin, adhesive strength testing, skin sensitization testing. Different supply chain, different raw materials.
Dimension 5 — Target demographic
Heat patches: broad demographic — adult office workers, elderly, athletes, outdoor workers, women (menstrual pain positioning). Low skin sensitivity, suitable for sensitive demographic. Capsicum plasters: adult athletes, working-age adults (muscle stiffness), elderly (circulation support). Higher skin sensitivity risk; pediatric and pregnancy typically cautioned.
Dimension 6 — Average price point (FOB China)
Heat patches: USD 0.03–0.12 per piece depending on size, heat duration, packaging, and order volume. Capsicum plasters: USD 0.05–0.15 per piece depending on size, capsaicin concentration, and order volume. Heat patches generally cheaper due to simpler raw materials.
2. 5 Market-Segment Mapping
Different markets favor different thermotherapy modalities based on climate, culture, and consumer preference.
Segment 1 — Japan and East Asia
Both modalities highly developed. Heat patches (known as "hokaron" or "kairo") dominant for cold weather warming and workplace comfort; capsicum plasters established for muscle stiffness. Japan particularly sophisticated with seasonal heat patch consumption patterns. Target buyers: drugstores, OTC brands, convenience retail.
Segment 2 — Europe
Capsicum plasters more established (traditional topical analgesic positioning); heat patches emerging (athletic recovery, wellness positioning). EU MDR Class IIa mandatory for capsicum plaster with capsaicin claims; heat patches positioned as cosmetic or Class I device. Target buyers: sports retail, pharmacy chains, wellness brands.
Segment 3 — North America
Heat patches dominant in winter seasonal retail and outdoor workforce segments. Capsicum plasters (e.g., Icy Hot, Salonpas, Aspercreme-style warming patches) strong in adult topical analgesic OTC segment. OTC monograph compliance critical for capsicum plaster if drug claims made. Target buyers: mass retail, pharmacy chains, hardware/sporting goods, online DTC.
Segment 4 — Middle East and GCC
Heat patches less established (climate less cold) but emerging in expat and indoor-cooled environment segments. Capsicum plasters dominant traditional warming positioning. GCC SFDA registration required for both. Target buyers: pharmacy chains, hypermarket retail, healthcare distributors.
Segment 5 — Southeast Asia and Latin America
Both modalities growing. Heat patches strong in colder climate areas (winter in southern Latin America, mountain regions). Capsicum plasters in working-age adult segments. Cost-competitive sourcing important. Target buyers: mass retail, pharmacy chains, regional distributors.
3. 4 Supplier Qualification Criteria
When sourcing both heat patch and capsicum plaster from the same OEM, use these 4 criteria to qualify the factory.
Criterion 1 — Dual-product regulatory documentation
Request sample regulatory documentation for both products from the factory. Verify the factory has FDA Facility Registration, EU MDR technical documentation, GCC SFDA registration, and NMPA medical device manufacturing license. Each product requires its own regulatory dossier.
Criterion 2 — Formulation expertise across both products
Request formulation white paper or technical data sheet for both products. Look for evidence of in-house formulation capability (vs. copying from a public formulation). For heat patches: iron-powder formulation expertise, heat profile optimization. For capsicum plasters: capsaicin extraction or synthetic capsaicin expertise, adhesive matrix formulation.
Criterion 3 — Manufacturing scale and cleanroom
Verify cleanroom classification for both product lines. Confirm capacity without cross-contamination (heat patches and capsicum plasters share some raw materials but require separate production lines to avoid cross-contamination). Request recent factory audit report.
Criterion 4 — Reference customers in both product categories
Request reference customer list (with permission to contact). Look for buyers in similar target markets. Verify the factory has experience serving buyers with similar regulatory and quality requirements.
4. 5-Step OEM Selection Framework
Step 1 — Define your product positioning and target market (week 1)
Decide: is your brand mechanical-heat-first (heat patch) or pharmacological-heat-first (capsicum plaster)? Which market(s) are you targeting? What regulatory pathway do you need? Document clearly before engaging factories.
Step 2 — Shortlist 6–10 dual-product factories (week 1–2)
Search Alibaba, GlobalSources, Made-in-China, Thomasnet. Filter factories that list both heat patch and capsicum plaster as core products. Request company profile, certifications, and FOB price ranges.
Step 3 — Request samples for both products (week 2–4)
Request both heat patch and capsicum plaster samples. Evaluate samples on: heat onset time, peak temperature, duration, adhesion quality, packaging, and label design. Compare side-by-side.
Step 4 — Documentation review and factory audit (week 4–6)
Review regulatory documentation, quality manual, and reference customer list. Visit top 2–3 finalists. Or commission third-party audit (SGS, Bureau Veritas, Intertek).
Step 5 — Pilot run and scale-up (week 6+)
Start with pilot run (10,000 units of each product). Verify: lead time, communication, batch quality, packaging, shipping. Then scale up to commercial volume. Plan Q2/Q3 production scheduling for Q4 retail demand (heat patches have strong winter peak).
5. FAQ (5 Questions)
FAQ 1: Can one factory produce both heat patch and capsicum plaster?
Yes, many OEM factories have both product lines because both are transdermal patch products with overlapping manufacturing infrastructure (cleanroom, packaging, regulatory team). However, some factories specialize in one or the other. Verify the factory's actual experience with both products before engaging.
FAQ 2: Which product has lower MOQ?
Both products typically have MOQ in the range of 5,000–50,000 units depending on factory, size, and packaging customization. Heat patches sometimes have lower MOQ due to simpler raw materials; capsicum plasters can have higher MOQ for stock sizes.
FAQ 3: How do I decide between mechanical and pharmacological heating?
Consider: (1) target market preference (Japan strong for both; MENA stronger for pharmacological), (2) target demographic (heat patches safer for sensitive skin / pediatric / pregnancy; capsicum plasters for athletic / muscle stiffness), (3) regulatory complexity (capsicum plasters face stricter monograph compliance in US/EU), (4) competitive landscape in your target market.
FAQ 4: Can the same factory supply both products under one private label brand?
Yes, this is common. The factory manages production scheduling to avoid cross-contamination. Your brand portfolio can include both mechanical and pharmacological warming products under the same parent brand with sub-line differentiation.
FAQ 5: What is the typical profit margin for thermotherapy patches?
Retail markup typically 4–8x FOB China price for mass retail; 8–15x for premium positioning; 3–5x for private label pharmacy distribution. Margin depends heavily on positioning, marketing investment, and competitive intensity.
6. Conclusion
Heat patches and capsicum plasters are complementary rather than competing product lines. Both serve thermotherapy positioning but with opposite heating mechanisms (mechanical vs pharmacological) and opposite target demographics (broad vs selective). A well-rounded B2B brand typically launches one modality first, then adds the second modality for portfolio completeness. For deeper analysis of heat patch OEM, see Heat Patch OEM Manufacturing Guide. For capsicum plaster OEM details, see Capsicum Plaster OEM Manufacturing Guide. For formulation comparison, see Capsicum Plaster Formulation Guide. For cooling gel patch comparison, see Cooling Gel Patch vs Capsicum Plaster.
If you would like to discuss thermotherapy positioning for your brand portfolio, including heat patch and capsicum plaster co-development, contact Henan Kangdi Medical Devices at kangdimedical@gmail.com or +86 155 1754 1011. We have supplied both heat patches and capsicum plasters to B2B buyers in 60+ countries since 1989 and welcome serious buyers for thermotherapy OEM / ODM / private label discussions.
References
- FDA 21 CFR 348 — Topical analgesic OTC monograph: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-348
- FDA — Facility Registration and NDC: https://www.fda.gov/drugs/development-approval-process-drugs/facility-registration-and-listing
- EU MDR 2017/745 — Medical Device Regulation: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745
- EU Regulation 1223/2009 — Cosmetics: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32009R1223
- GCC SFDA — Saudi Food and Drug Authority: https://www.sfda.gov.sa/en
- China NMPA — National Medical Products Administration: https://www.nmpa.gov.cn/
- ISO 13485:2016 — Quality management systems: https://www.iso.org/standard/59752.html
- ISO 22716:2007 — Cosmetic GMP: https://www.iso.org/standard/36494.html
- ASTM F2871 — Heat patch testing: https://www.astm.org/
- JIS Z 8806 — Temperature measurement: https://www.jsa.or.jp/
- WHO — Pediatric fever management: https://www.who.int/publications/i/item/9789241548096
- China Customs HS code 3004.90 — Transdermal patches: https://www.chinacustoms.gov.cn/
- China Customs HS code 3824.99 — Chemical preparations: https://www.chinacustoms.gov.cn/
- PubChem — Capsaicin: https://pubchem.ncbi.nlm.nih.gov/compound/Capsaicin
- Third-party audit firms (SGS, Bureau Veritas, Intertek): https://www.sgs.com/ / https://www.bureauveritas.com/ / https://www.intertek.com/
Contact: For OEM/ODM inquiries, email kangdimedical@gmail.com or call +86 155 1754 1011.Updated: August 2026. Information current as of publication date. Regulatory frameworks and quality system requirements evolve continuously. Always verify current regulatory requirements with qualified regulatory counsel and confirm factory qualifications with current documentation, independent audit, and reference checks before finalizing sourcing decisions.